Becton Dickinson Licensing Deals Under Scrutiny

Law360, New York (April 25, 2007, 12:00 AM EDT) -- Becton Dickinson and Co. is facing arbitration and dispute resolution proceedings in Europe initiated by a French medical testing company over staph infection detection and blood culturing patents, the medical technology giant announced Wednesday.

In a letter received by Becton Dickinson on Tuesday, French company bioMérieux SA said it had initiated an arbitration proceeding with the ICC International Court of Arbitration in Paris against BD subsidiary GeneOhm Sciences Canada. bioMérieux wants to terminate a sublicense agreement in which it granted GeneOhm rights to a method for...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.